A study to assess the pharmacokinetics and safety of different forms and formulations of AZD9496 in healthy subjects

Trial Identifier:	D6090C00005
Sponsor:	AstraZeneca
Collaborator:	PAREXEL
NCTID::	NCT02780713
Start Date:	June 2016
Primary Completion Date:	September 2016
Condition:	Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, MD	Baltimore, MD, United States of America, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.